Discover The Advantages of a Continuous Assay For Kinetic Characterization

Sponsored by Biogenuix

Webinar Overview:

Traditionally, endpoint assays have been used to determine inhibitor potency, uncover compound selectivity, and characterize compound-dependent kinetics. However, these assays may miss critical kinetic insights. A continuous assay format offers distinct advantages over the endpoint format because it directly captures the actual reaction rate using dozens of time points in a single well, yielding much higher confidence in this critical parameter. With these additional kinetic observations, you get deeper insight into the compound mode of action.

Join our webinar to learn how our PhosphoSens® continuous assays provide more kinetic insights.

You’ll learn:

  • The differences between an endpoint and continuous assay
  • What can your data tell you? How to uncover kinetic insights that lie behind the raw data
  • Examples of interesting progress curves and how to use them to identify aspects of an inhibitor’s mode of action

Meet Your Presenter:


Earl May, Ph.D., Senior Director of Discovery Technologies

Earl has 25+ years of expertise in drug discovery and enzymology from GSK, OSI and several other biotechnology companies. He has used our Sox sensor peptide technology at all companies he had kinase inhibitor programs, with both reversible and covalent compounds.

Watch Now!

Stay Informed

Want to hear the latest about our technology? Be among the first to learn about our latest products and services.